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ABSTRACT 
 
 
The primary aim of this study was to examine the effects of exercise induced 
muscle damage on critical torque and impulse above end test torque. A secondary 
purpose was to determine whether mitochondrial function played any role in observed 
changes. A total of 12 participants performed resting mitochondrial tests, MVC level 
tests, and a 5-minute all-out isometric knee extension test for critical torque both before 
and 48-hours following exercise induced muscle damage via electrical stimulation and 
eccentric isokinetic knee extension. Surface EMG was collected during the critical 
torque tests to ensure full effort was given. The muscle damage protocol was successful 
in seven of the participants. Of those seven, one was excluded for mitochondrial 
function analysis due to being an outlier. The primary findings were that exercise 
induced muscle damage 1) results in a reduced critical torque, 2) a reduced impulse 
above end test torque and 3) did not alter mitochondrial function in the working muscle. 
These findings could indicate that although oxidative capacity plays a large role in 
determining critical torque, there is more at play due to the lack of change in 
mitochondrial function. The drop in impulse above end power indicates the importance 
of muscular work capacity. 
 
1 
CHAPTER I 
INTRODUCTION 
 
Exercise tolerance can be a large determinant of performance in sport, and the 
resolution of its physiological basis is therefore a significant goal in exercise 
physiology. Exercise intensity can be separated into multiple domains based upon the 
energy demand of the activity [1]. The first domain is the moderate-intensity domain, 
which encompasses exercise below lactate threshold. Exercise in the heavy domain 
occurs above lactate threshold however despite an initial upward drift past expected 
values, physiological processes such as ventilation, pH, and VO2 will still reach a steady 
state [2]. The final domain is the severe-intensity domain where physiological 
parameters will not reach a steady state, and VO2 will progressively increasing until 
volitional fatigue is reached (49). The “threshold” or transition between the heavy 
intensity domain and the severe intensity domain has been termed “critical power” [3]. 
Critical power (CP) represents the upper limit of exercise intensity for prolonged 
aerobic exercise, and, theoretically, this power output could be sustained indefinitely 
[4]. Any work performed above CP will tap into a finite energy store termed W’. W’ 
represents a fixed amount of work and as such exhaustion or exercise termination will 
depend on the rate at which this work is used or depleted during a bout of exercise (e.g. 
W’ will be depleted slower and thus exhaustion will occur later at an intensity slightly 
above CP compared to an intensity that is well above CP) [5]. 
 In any sport played at intensity sufficient to spend significant time in the severe 
domain, CP will become an important factor in determining exercise tolerance. CP has 
been shown to be generalizable to multiple exercise modalities such as cycling [6], 
running [7] and rowing [8]. CP has also been reliably determined using multiple 
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different exercise protocols. The criterion protocol involves multiple continuous 
exercise bouts at various intensities, presumably over CP in which exhaustion occurs 
within 3-15 minutes. Power output is then plotted against time-to-exhaustion (Tlim), 
resulting in a hyperbolic relationship in which the asymptote represents CP [9]. A 
single-bout 3-minute sprint protocol, which reaches a steady state in the last 30 seconds, 
has also been shown to yield a reliable measure of CP [10]. When isometric 
contractions are performed a similar relationship is observed, however because 
isometric exercise lacks a displacement CP is renamed as critical torque (CT).  Recently 
a single-bout 5-minute maximal isometric knee extension protocol was validated as it 
was shown to produce CT values similar to a more traditional multiple bout protocol 
[11]. This protocol will be employed in the presented study. 
 It is well accepted that strength training improves performance not only in 
strength sports, but also in endurance sports such as running and cycling [12, 13].  
Strength training improves movement economy and movement patterns through 
changes in motor-unit recruitment [14]. Such training tends to involve a large eccentric 
component which often results in exercise-induced muscle damage (EIMD) [15]. EIMD 
results in alteration to skeletal muscle structure and function [16] which leads to 
decreased force production and physical performance as well as delayed on-set muscle 
soreness (DOMS). EIMD and its associated force loss have been shown to reduce 
movement economy, or the amount of energy necessary to perform a task in relation to 
the work accomplished, in running conditions [17]. This means an individual has to use 
more energy for the exact running task following EIMD. Damage has also been shown 
to reduce maximal oxygen consumption (VO2peak) during cycling exercise [18] and 
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during running [19]. The reductions have been shown to persist for up to 7-10 days 
[19]. However, the mechanisms by which these effects occur remain unclear. Reduced 
performance has been suggested to be linked to central factors such as inflammatory 
cytokines in brain areas responsible for fatigue, pain perception, and motivation which 
could result in an earlier onset of centrally mediated volitional fatigue [20].  
Conversely, some effects of EIMD are clearly related to peripheral factors, as disruption 
of sarcomeres will impair the formation of cross-bridges and damage to the 
sarcoplasmic reticulum leads to impairments in excitation-contraction coupling (REF).  
 The there is also evidence EIMD impairs oxidative metabolism on the cellular 
level, although this is not universally supported. A recent study found that severe EIMD 
caused by neuromuscular electrostimulation (NMES) resulted in intramuscular acidosis 
at rest and impairment of mitochondrial function during exercise [21]—suggesting that 
in addition to sarcomere and sarcoplasmic reticulum damage that eccentric exercise 
may also damage mitochondria. Conversely, following 30 minutes of eccentric cycling, 
no impairments in oxidative metabolism were observed [22] and a study employing P31-
magnetic resonance spectroscopy found that reduced exercise tolerance was not a result 
of an increased use of anaerobic metabolism [20]. Thus it remains somewhat unclear as 
to whether oxidative metabolism is or is not affected by EIMD—and whether 
impairment in oxidative metabolism might underlie the observed decreases in VO2 peak 
and aerobic exercise performance.   
While CP remains mechanistically unresolved, oxygen availability has been 
shown to play a key role. The inspiration of hyperoxic gas was shown to increase CP 
and delay time-to-exhaustion [5] while inspiration of hypoxic gases decreases CP and 
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time-to-exhaustion [23] during cycling exercise. Additionally, Broxterman et al. [24] 
recently demonstrated that when blood flow to the exercising limbs was occluded that 
CP fell precipitously. These findings clearly highlight an important role the aerobic 
metabolism in determining CP.  Therefore, if EIMD results in compromised oxidative 
function it could also adversely affect CP and this reduction in CP could account for the 
reduced exercise tolerance observed following EIMD [18, 19].  
 
Thus the Purpose this study was: 1) to determine whether EIMD in the knee extensors 
affects the work-time relationship and its associated parameters of CT and Impulse 
Above End Test Torque (IAT, an analogue to W’) as determined during isometric knee 
extensions and 2) to determine whether EIMD alters mitochondrial function (oxidative 
capacity) of the quadriceps muscles.   
 
Research Questions:  
1) Does eccentric exercise resulting in EIMD result in a decrease of CT and IAT’? 
2) If CT is decreased, is this decrease due to impaired oxidative capacity? 
 
Null Hypotheses 
1. There will be no change in critical torque 48-hours following a bout of eccentric 
exercise that results in EIMD 
2. There will be no change in IAT 48-hours following a bout of eccentric exercise 
that results in EIMD 
3. There will be no change in NIRS assessed mitochondrial function 48-hours 
following a bout of eccentric exercise that results in EIMD 
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Research Hypothesis: 
1. There will be a decrease in critical torque 48-hours following a bout of eccentric 
exercise that results in EIMD 
2. There will be a decrease in W’ 48-hours following a bout of eccentric exercise 
that results in EIMD 
3. There will be  a decrease in NIRS assessed mitochondrial function 48-hours 
following a bout of eccentric exercise that results in EIMD 
 
Delimitations: 
1. The results will only be able to be generalized to healthy individuals in the age 
range of 18-40 
2. The results will only be able to be generalized to the knee extensor muscles 
 
Limitations: 
1. The sample will not be random; it will be a convenience sample 
2. Participants will be asked to refrain from heavy lower body exercises outside of 
laboratory setting throughout the protocol  
 
Assumptions: 
1. Participants will give a maximal effort during CF testing 
2. Participants will provide accurate medical history 
3. Participants will give a maximal effort during muscle damage protocol 
4. Reliability and validity of protocol was properly established by prior research 
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Operational Definitions: 
1. Critical power/critical torque: The power output which can be sustained 
theoretically indefinitely; the upper limit to wholly aerobic work demarcating 
the heavy and severe intensity domains [4] 
2. Lactate Threshold: The point at which lactate entry into the blood exceeds its 
removal [25]  
3. W’/ Impulse Above Critical Torque: The finite work capacity one is able to 
perform above CP; a combination of anaerobic metabolism and intramuscular 
oxygen stores [26] 
4. Exercise Intolerance: The point at which one can no longer perform a exercise 
at a given intensity [3] 
5. VO2: The amount of oxygen utilized by the body [27]  
6. VO2 Peak: Maximal ability of the body to use oxygen [18]  
7. Exercise-Induced Muscle Damage: Damage to muscle structure brought upon 
by exercise training, especially eccentric muscle contractions [15] 
  
7 
CHAPTER II 
REVIEW OF LITERATURE 
 
The proposed problem is to identify whether or not EIMD attenuates CF as 
determined by an isometric handgrip test. To gather background information on the 
subjects of EIMD and CF, a systematic review of literature was conducted (refer to 
table at the conclusion of this chapter). Online academic databases were scanned for 
pertinent articles. Articles were excluded primarily for non-relevant interventions such 
as diet, or if the research examined a specific ‘non-healthy’ population (i.e. chronic 
diseases). 
 
Critical Power 
The evidence for an inversely proportional relationship between duration of high 
intensity exercise and power output began to be established in 1927 by A.V. Hill, when 
Hill first plotted world records for male and female swimming and running time vs. 
average speed [28]. Hill observed a ‘power-duration’ relationship which is best 
described by a hyperbolic function, whereas power increases, time to exhaustion (Tlim) 
is shortened. As power output decreases, Tlim approaches an asymptote that signifies a 
rate muscles can perform at theoretically indefinitely, termed ‘critical power’. This 
power represents the limit of wholly aerobic energy output [4]. Work done above 
critical power (CP) has a finite capacity which is termed W’.  This relationship can be 
transformed into a linear formula which reads P=(W’/t)+PLL , with W’ as the slope and 
PLL  as the intercept [6]. 
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  CP has been demonstrated to lie between the lactate threshold and VO2Max 
[23]. The exercise intensity between CP and lactate threshold has been deemed the 
‘heavy domain’, where lactate accumulation and VO2 slow component will be present, 
however will attain a steady state. Intensities supra-CP are deemed ‘severe’, where VO2 
will approach or exceed maximum levels and result in a predictable exhaustion [3].  
 To determine CP, Monod and Scherrer developed a protocol involving multiple 
dynamic exercise tests to local muscular exhaustion. Tests at various constant power-
outputs were performed to Tlim . When force was plotted against Tlim, a hyperbolic 
relationship emerged. A linear relationship also existed between the total work done at 
each rate and the Tlim. The slope of this relationship is deemed critical power [6].  
 Monod’s and Scherrer’s findings were extended to total body exercise by 
Moritani et. al [9]. Moritani used an electrically braked cycle ergometer to determine 
VO2 peak during a ramp protocol, as well as CP using 3 dynamic work tests in similar 
fashion to Monod and Scherrer. Moritani found a linear relationship between total work 
and Tlim in whole body exercise just as in localized exercise, making it possible to 
calculate Tlim based on power output [9]. 
 In the same study, Moritani concluded that CP was oxygen dependent. 
Conducting the multiple exhaustive trials at different levels of inspired O2, it was found 
that hypoxic conditions decreased the slope of the relationship predictably (CP), while 
the intercept (W’) remained unchanged [23]. The concept of CP being O2 dependent 
was further reinforced in hyperoxic conditions, which where shown to increase CP 
estimates. Levels of PCr were found to decrease less rapidly, which resulted in extended 
Tlim per power output [5]. 
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 Determining CP with the methods described thus far would take anywhere from 
3 to 7 or more laboratory visits and tests, which could prove to be inconvenient when 
coupled with other manipulations. The need for a test protocol that estimates the heavy-
severe exercise domain boundary more efficiently arose. Vanhatalo et. al. [10] observed 
the critical power formula P=W’/t+CP, and hypothesized that if W’ was fully depleted 
(W’=0), P=CP. Having already established that a 3-minute all-out cycling test produced 
a repeatable power profile that reaches a steady state in the final 30-60s in an earlier 
study, it was tested whether this final power level was different from CP. When tested 
against the traditional multi-bout method, the end power during the 3-minute all-out test 
was no different from critical power. The work performed above end power was also 
not significantly different from W’. This was the first study to provide a method of 
determining the two parameters of the power-duration relationship in one laboratory 
visit [10]. 
 Constantini et. al. [29] established the validity of a single session furthermore by 
combining a ramp protocol followed by a 3-minute all-out test. The combinations of 
these two tests allowed determinations of all exercise intensity boundaries in one 
laboratory visit. Furthermore, this study found that a familiarization trial for the 3-
minute all-out test was not necessary, making determination of CP even easier. A 
similar combination of ramp test and sprint protocol was conducted by Murgatroyd et. 
al., using the ramp to indicate lactate threshold and Vo2 max, and the sprint to 
determine CP, reached the same conclusion [30]. 
With external validity always a concern with research, it is necessary to ensure 
laboratory-based concepts can be applied to the real world. One study tested the 
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multiple- bout test to determine CP in a velodrome. Three all-out tests of different 
duration were compared with CP determined in a lab setting, and were found to have 
very high agreeability[31]. Another study investigated the validity of CP tests 
performed on a rowing ergometer, both in all-out fashion and multiple constant work 
rates to exhaustion.  End power was found to be highly correlated with CP, displaying 
the 3-minute all-out tests validity for various exercise modalities [8]. 
While W’ is still not well understood, there is evidence that CP is a very 
consistent measure. As CP demarcates the limit of completely aerobic exercise, any 
preceding exercise has been proven to not impact it. In addition, since exercise below 
CP should be wholly aerobic and sustainable in nature, power outputs at this level 
should not, and have been proven to not, affect W’. Research studies have shown that 
exercise preceding a 3-minute all-out test above critical power deplete W’, while have 
no effect on CP [26], as well as full out sprints prior to a 3-minute all-out test do not 
affect CP, regardless of recovery time [32]. 
The application for all-out critical power tests has recently been further extended 
to different contraction modalities and techniques. As opposed to the isotonic 
contractions that have been covered in this chapter thus far, a recent study utilized 
isokinetic cycling at two different rotations per minute (rpm). Trials were set at 100 and 
60 rpm, and found that both models had high agreeability with each other as well as 
other CP protocols in terms of end power (CP) and work above end power (W’)[33]. 
Isometric knee extension exercise has also been studied in an attempt to validate the 
torque-duration relationship. The protocol involved multiple tests with varying MVC 
percentages to failure compared against 60 isometric MVCs for 5 minutes (3s 
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contraction, 2 s relaxation), and found that this 5-minute MVC test appropriately 
predicted critical torque [11]. 
Most recently, Tschekovsky et. al. have began research on single-bout critical 
force (CF) tests using the forearm. The repeatability and validity of the critical force 
estimate from a maximal effort rhythmic isometric handgrip exercise test, as well as 
whether this would be a good indicator of CP was examined. These trials consisted of 
maximal effort rhythmic isometric handgrip exercises. Participants then completed two 
additional visits to exhaustion at 10% above CF, or 10% under CF capped at 20 min. 
The forearm grip protocol resulted in the same pattern of force decay to a level force as 
demonstrated in other exercise protocols. This plateau in force had good repeatability, 
and accurately predicted TTE for work supra-CF [34].  
The research presented displays that this indefinite energy level can be applied 
to multiple modalities. Therefore choosing CF as our model will allow for more 
measurements due to its isometric nature. The consistency of CF and CP measurements 
makes it a very suitable method for assessment, and will allow reliable conclusions to 
be drawn from the proposed intervention. 
  
Exercise Induced Muscle Damage 
Exercise induced muscle damage (EIMD) is a phenomenon that anyone 
physically active has experienced at some point in their lives. It has been well 
established that eccentric contractions injury muscle more severely than concentric and 
isometric contractions. Armstrong et. al. investigated the effect of running on incline, 
flat, and decline planes in rats [15]. Decline running is primarily eccentric in nature, 
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while incline is concentric, with flat running being a mix of both. Armstrong et. al. 
assessed markers of muscle damage after putting rats through a running protocol. These 
markers include plasma creatine kinase (CK) and lactate dehydrogenase (LDH) levels, 
glucose-6-phosphate dehydrogenase (G-6-PDase), and histological observations. CK 
and LDH are usually located inside the muscle, so elevated plasma levels indicate 
damage of muscle cell’s structure [35, 36]. G-6-PDase activity has been shown to be 
associated with the inflammation and repair process of skeletal muscles [37]. Armstrong 
et. al.’s results from 1983 clearly display greater muscle damage in downhill running 
than level. Immediately after exercise, plasma LDH and CK levels were significantly 
higher in declined runners than other running conditions, with a secondary elevation 
1.5-2 days later. This secondary elevation was absent in the other conditions. 
Significant increases in G-6-PDase activity were observed in downhill runners and to a 
lesser extend in uphill runners, with no increases in level runners. Downhill runners also 
exhibited greater muscle disruption in the histological analysis [15]. Eccentric exercise 
has been shown to have the same effect in humans as it does in rats. Davies et. al. 
employed a box stepping protocol, with one leg performing the eccentric portion, and 
the other the concentric. Their results indicated that long lasting muscle weakness was 
observed in the eccentric leg, with minimal weakness observed in the concentric leg. It 
has been proposed that eccentric contractions cause more damage due to their 
recruitment of fewer motor units per given force [38, 39]. 
EIMD has been suggested to affect type 2 fibers more than type 1 fibers. In 
rabbit models, cyclic eccentric contractions cause similar changes to muscle as in 
humans. It was also found that type 2 fibers were selectively damaged [40].  The extent 
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to which EIMD injuries the musculature also depends on multiple factors. Warren et. al. 
investigated whether EIMD is larger in a single high stress contraction, or several 
contractions accumulated. Using rat soleus, muscles were eccentrically contracted 
between 0 and 10 times, and found that cumulative contractions result in significantly 
higher muscle damage [41].  It has also been shown that extending the duration of 
lengthening increases the damage. One study reported that the extent of injuries 3 days 
post EIMD increased with duration of the eccentric contraction up to 5 minutes in mice, 
however extending the lengthening beyond 5 minutes yielded no more damage. It was 
suggested that this lack of extra damage was due to loss of peak force. The same study 
varied peak force with the same lengthening velocity, and found muscle damage was 
positively correlated with peak force [42].  Talbot et. al. concluded that initial muscle 
length impacted EIMD [43]. Brooks & Faulkner found in 2001 that contraction velocity 
plays a minimal role in EIMD if muscle strain is not significant enough, and that muscle 
strain is a much better determinant of damage [44].  All these studies combined go to 
show there are many factors that play roles in determining the severity of EIMD per 
protocol.  
Muscle damage causes multiple performance impacts. One study examined 
running economy before and after EIMD measured oxygen consumption, ventilation, 
respiratory exchange ratios (RER), heart rate, blood lactate, and rating of perceived 
exertion (RPE) at different percentages of Vo2Peak. Increases in heart rate, ventilation, 
RPE, RER, and blood lactate were observed following EIMD. There was also a 
reduction in stride frequency, stride length, and range of motion in the ankle and knee 
joints. This effect persisted for 3 days after EIMD, suggesting that damage reduces 
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exercise economy [17].  VO2 peak and ventilatory threshold have been shown to be 
reduced following eccentric exercise in cycling protocols [18].  Another study looking 
at time-trial performance found similar results, with EIMD causing a decreased power 
output, distance covered and VO2 [45]. In isometric maximum voluntary contractions, 
following EIMD, absolute strength has displayed detriments, while rate of fatigue was 
decreased. The authors suggested this might be due to a selective damage of type 2 
fibers, resulting in increased reliance on fatigue resistant type 1 fibers [46].  
P-MRS studies have indicated that there is an increased level of resting 
inorganic phosphate post EIMD, which suggests a higher resting muscle metabolism 
[47]. These higher resting inorganic phosphate levels may be responsible for a reduced 
exercise tolerance in damaged muscles, as damaged and undamaged muscles both reach 
the same absolute level of inorganic phosphate at exhaustion, and temporally there is 
not a greater depletion of PCr after damage [20]. This lack of a faster decrease in PCr 
levels discounts higher contributions of nonoxidative energy [20]. Using near infrared 
spectroscopy (NIRS), it has also been shown that EIMD slows deoxyhemoglobin 
kinetics, slowing the extraction of oxygen from the blood during the onset of exercise. 
The VO2 kinetics are preserved, however, by an increase in blood flow to the damaged 
muscle [27].  Studies on mice have found that eccentric exercise impairs mitochondrial 
function, making them more susceptible to mitochondrial permeability transition pores 
(MPTP). These pores can result in a lesser production of ATP, and cell death [48].  As 
mitochondria are the sight of aerobic metabolism, this may serve to explain some of the 
metabolic changes presented above. Research in humans has yielded contradictory 
advice. Walsh et. al. found that high intensity eccentric exercise did not reduce muscle 
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oxidative function, and that muscle oxygen utilization and transport are unchanged at 
rest [22]. Foure et. al. [21] recently found results conflicting with those of Walsh et. al 
[22]. Using isometric neuromuscular electrostimulaton (NMES) to induce damage 
larger than that of voluntary contractions, Foure et. al. [21] observed impaired 
mitochondrial function in exercising muscle, as well as elevated intramuscular acidosis 
in resting muscles. PCr recovery was slower, as well as reduced oxidative ATP 
indicated deficiency in mitochondria [21].  
More research is required on this subject to further develop our understanding of 
muscle damage’s impact on the metabolic properties of muscle. Due to CF being the 
limit to wholly aerobic exercise, a decrease in CF resulting from EIMD could very 
reasonably give evidence toward compromised metabolic processes. Such evidence 
would be helpful in understanding and fine tuning training and recovery programs for 
athletics, as well as stimulating further research.  
 
Near Infrared Spectroscopy  
Near Infrared Spectroscopy (NIRS) is a noninvasive method to determine 
muscle O2 saturation in the small vessels. Near infrared light penetrates the tissue and 
either gets absorbed by oxy- and deoxy-hemoglobin or scattered[49]. The near infrared 
light wavelengths (670 nm – 900 nm) provide a unique window where absorption 
properties of tissue can be measured as the oxygenated and deoxygenated molecules 
have its own absorption spectra[49]. Oxy and deoxyhemoglobin absorb 800 nm light 
equally; however at 760 nm the absorption is primarily deoxyhemoglobin. Monitoring 
these wavelengths therefore provide an index of deoxygenation. Scattering of the signal 
is measured directly by the device and accounted for[49].  
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During an extended bout of exercise, muscle will rely on the oxidative energy system. 
NIRS has been used to evaluate recovery of oxygenated hemoglobin, a measure that 
determines the balance of oxygen delivery to oxygen consumption. Measurements made 
under occlusion results in oxygen delivery and venous return to be cut out, and thus 
measuring only oxygen consumption. The rate of oxygen consumption under these 
conditions can be used to determine rate of PCr recovery[50]. After exercise, the PCr 
system is recovered via mitochondrial ATP production, and therefore is a measure of 
oxidative capacity. Nagasawa et al. (2003) compared time constants (Tc) for PCr 
recovery as determined by NIRS against the criterion method of P-MRS[51]. Following 
forearm exercise protocol, blood flow to the forearm was occluded every 20 seconds for 
ten seconds at a time up to 180 seconds, and every 30 seconds up to 600 seconds. 
During occlusion, oxygen consumption was determined using NIRS. This protocol was 
repeated twice, with the second time being 10 seconds offset from the first. This 
allowed having twice as many measures of oxygen consumption. Plotting the slopes of 
oxygen consumption over time resulted in the ability to determine a Tc for the NIRS 
data. This NIRS determined Tc was found to be significantly correlated with measures 
made by the P-MRS and thus a valid indicator of oxidative capacity[51]. Cross-
validation of NIRS with P-MRS indexes of muscle oxidative capacity has proven NIRS 
to be valid for assessing mitochondrial function [50]. These findings have been shown 
to be independent of exercise intensity, and to have a high degree of reliability and 
reproducibility[52]. 
 
 
17 
CHAPTER III 
METHODOLOGY 
 
Participants 
 The University of Oklahoma’s institutional review board for research on human 
subjects provided ethical approval for the experiment. Participants provided verbal and 
written informed consent. Once informed consent was obtained, participants were asked 
to complete a health and physical activity readiness questionnaires (PARQ) prior to any 
testing. Twelve participants volunteered (females=4, males=8) for and completed the 
study. Of those 12, only 8 participants demonstrated a >5% reduction in maximal 
voluntary strength (MVC) of the quadriceps from pre-damage to 48-hours post-damage. 
The 4 participants who did not demonstrate a reduction in MVC were judged to have 
not experienced EIMD and were therefore excluded from analysis. A sample of 8 was 
sufficient to detect an effect of 0.42 SD at an alpha level of 0.05, a power of 0.80, and 
assuming a correlation between repeated measures of CT of 0.95 [53].  
 Participants were required to arrive at the laboratory in a rested state, having 
performed no heavy exercise in the last 24 hours, and to have refrained from food and 
beverage in the previous 3 hours. Participants were also asked to refrain from the use of 
anti-inflammatories and/or any other pain medications for the duration of the study and 
to refrain from any therapeutic modality (ice, massage, etc.) following the eccentric 
exercise protocol. Compliance with these instructions was confirmed at the beginning of 
each testing session. All trials were performed at roughly the same time of day (within 2 
hours).  
 Due to participants being volunteers, a non-probability sampling technique was 
necessary and recruitment occurred in the Norman, OK area by fliers, mass-email and 
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word of mouth.  Males and female participants were used due to evidence they 
experience a similar magnitude of EIMD following eccentric exercise [54, 55]. All 
participants had not participated in resistance training with their quadriceps for the 
previous 6 months.  
 
Experimental Design 
 A repeated measures design was used whereby each participant was assessed 
prior to and 48-hours post muscle damage. Following 2 familiarization sessions, critical 
torque of the knee extensors was assessed using a previously validated [11] 5-minute 
isometric knee extension exercise protocol where participants performed a series of 
maximal voluntary contractions for 3 seconds followed by 2 seconds of rest (60 total 
contractions).  Electromyography (EMG) was collected from the contracting quadriceps 
during the CT test.  Mitochondrial function was assessed prior to the CT test using 
NIRS as described previously [50].  
 
Visit 1 & 2 (45-60 minutes each) – Familiarization The first two visits were to 
familiarize subjects to location and protocol. The participant was seated on a KinCom 
isokinetic dynamometer in the proper positioning, and with their hip placed at 
approximately a 90 degree angle. KinCom setting were noted for each participant to 
allow consistency between trials. Straps were placed across their chest to secure them to 
the seat. The ankle of their dominant leg was secured to the dynamometer lever such 
that their knee rests at an angle of 70 degrees below horizontal. Electrodes were placed 
on the bellies of the vastus medialis and vastus lateralis muscles. The participants then 
performed three maximal voluntary isometric contractions of the quadriceps. Following 
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the three MVCs, participants were familiarized to electrical muscle stimulation. 
Participants then conducted a familiarization to the critical torque assessment, and to the 
cuff inflations to be utilized for the near-infrared spectroscopy assessment.  
Visit 3 (60-75 minutes) – Baseline Mitochondrial Function and Critical Torque 
Assessment Participants arrived to the lab, and assumed a resting supine position on the 
bench for 15 minutes. Blood pressure was taken prior to any testing. The NIRS probe 
was then placed on the belly of the vastus medialis muscle.  Near-infrared spectroscopy 
assessment of mitochondrial function was then performed twice. The participants were 
then seated in the KinCom, and EMG electrodes were placed on their vastus lateralis 
muscle belly. The participants were then instructed to perform three sets of MVCs. 
Following a three minute break, the participants performed the critical torque 
assessment. 
Visit 4 (30-45 minutes) – Eccentric Exercise Upon arrival, participants were asked to 
perform a muscle soreness assessment. They were then seated and properly secured into 
the KinCom. The participants then performed three sets of MVCs. The current to be 
used during the muscle damage protocol was then determined followed by the eccentric 
exercise protocol. Upon completion of the protocol, muscle soreness was reassessed.  
Visit 5 (60-75 minutes) - Mitochondrial Function and Critical Torque Assessment 
Following EIMD Participants arrived to the lab roughly 48-hours after visit 4, and 
muscle soreness was assessed. They then assumed a resting supine position on the 
bench for 15 minutes. Blood pressure was taken prior to any testing. The NIRS probe 
was then placed on the belly of the vastus medialis muscle.  Near-infrared spectroscopy 
assessment of mitochondrial function was then performed twice. The participants were 
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then seated in the KinCom, and EMG electrodes were placed on their vastus lateralis 
muscle belly. The participants were then instructed to perform three sets of MVCs. 
Following a three minute break, the participants performed the critical torque 
assessment.  
 
Experimental Procedures 
Current Determination 
 Participants were seated in the KinCom as previously described. Electrodes 
were placed on the vastus medialis and vastus lateralis muscles. Isometric contractions 
were evoked using 100 Hz electrical stimulation at the highest stimulation amplitude 
each participant could tolerate.  
 
Maximal voluntary isometric contraction of the quadriceps  
 The participant was seated on the KinCom in the proper position described 
previously. The participant was asked to perform a maximum voluntary contraction 
using their dominant quadriceps muscle group.  Participants were asked to contract their 
quadriceps as forcefully as possible such that their ankle “kicks” against the pad on the 
dynamometer lever. Each contraction lasted 3 seconds, three total contractions were 
performed, and 3 minutes of rest separated each contraction. 
 
Familiarization to critical torque assessment  
 A 2 minute rest period was followed by a 2-minute exercise protocol where 
participants performed a series of MVC’s with their dominant quadriceps. Each MVC 
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lasted 3 seconds, followed by a 2 second rest period—exercise continued in this manner 
for 2 minutes (12 total contractions will be performed).  A metronome as well as verbal 
queuing was provided to assist participants in becoming familiar with the contraction 
cadence. Visual feedback of the torque produced during the MVC was provided to the 
participants. The critical torque testing protocol involved performing contractions in 
this manner for 5 minutes. Only 2 minutes of exercise were performed during this 
familiarization session in an effort to limit fatigue, but allow participants to learn the 
contraction cadence. 
 
Familiarization to near-infrared spectroscopy assessment of mitochondrial 
function  
 Following a 5 minute rest period, participants were familiarized to the 
procedures for determining their mitochondrial function. Participants lied in a supine 
position on a padded table. The ankle of their dominant leg was placed on a raised, 
padded brace such that their lower leg and knee and slighted elevated from the table. A 
blood pressure cuff was placed around their thigh, approximately 10-15 cm distal to 
their inguinal ligament. The cuff was attached to a rapid cuff inflation/deflation 
pneumatic system. The cuff was inflated to ~250-280 mmHg (consistent with previous 
studies) to occlude blood flow distal to the cuff. The cuff was inflated for 30 seconds, 
released, and then participants will rest for 3-5 minutes. The cuff was again inflated for 
30 seconds, released and a recover period of 3-5 minutes was allowed. Next, a series of 
cuff inflations and deflations, each lasting 10 seconds was performed. This was done for 
1 minute (3 inflations and 3 deflations). This procedure was performed to familiarize 
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participants to the location of the cuff placement, and to the sensations that occur during 
cuff inflation/deflation. 
 
Near-infrared spectroscopy assessment of mitochondrial function  
 Participants were placed in a supine position on a padded table with their lower 
leg elevated as described above.  The blood pressure cuff was placed around their upper 
thigh as described in the familiarization.  The near infrared spectroscopy probe was then 
be placed over the belly of the vastus lateralis. Placement location was determined by 
use of anatomical landmarks, palpation, and 2D Doppler ultrasound of the site. After a 
3-5 minute rest period the cuff was inflated to ~250-280 mmHg for 60 seconds. It was 
then released and participants rested for 3-5 minutes. The cuff was again inflated to 
~250-280 mmHg for 60 seconds, released and followed by a 3-5 minute rest period. 
After the rest period the participant performed a brief (20 seconds) knee extension 
exercise protocol was performed to raise the metabolic rate in the quadriceps muscle 
group. Immediately following the exercise protocol the blood pressure cuff around the 
thigh was inflated to ~250-280 mmHg for 10 seconds, released, and a 10 second 
recovery period was given. A series of 10 second inflations and 10 second deflations 
continued for 5-6 minutes (for a total of 15-18 periods of inflation). Following the final 
deflation a 2-3 minute rest period was be provided. 
 
Critical torque assessment  
 Participants were seated on the KinCom in the same manner as in maximal 
voluntary isometric contraction of the quadriceps. Surface electromyography electrodes 
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were placed over the belly of the vastus lateralis muscle. Position was determined by 
anatomical landmarks and palpation. The location of electrode placement was shaved to 
remove and hair and dead skin cells and then cleaned with alcohol. The near infrared 
spectroscopy probe was then be placed over the belly of the vastus lateralis. Placement 
location was determined by use of anatomical landmarks, palpation, and 2D Doppler 
ultrasound of the site. The NIRS probe and EMG electrodes were secured in place using 
surgical tape and elastic wraps. Next, participants performed a series of MVC’s to the 
cadence of 3 seconds of contraction followed by 2 seconds of rest for a period of 5 
minutes (60 total contractions) to determine their critical torque. Participants had the 
assistance of a metronome, as well as visual and verbal feedback to help them provide a 
maximal effort for each contraction. 
 
Muscle soreness assessment  
 The participant performed a rating of their perceived muscle soreness/pain in 
their dominant quadriceps muscle group. Participants performed a single legged squat 
and then used a 10 cm visual analog scale (VAS) to rate the pain/soreness experienced 
in their quadriceps.  
 
Eccentric exercise protocol  
 Participants performed an eccentric exercise designed to induce muscle damage. 
While seated on the KinCom, maximal isokinetic eccentric contractions of the knee 
extensors will be performed. Participants initially performed 4 sets of 10 contractions at 
30 degrees per second with 3 minutes of rest provided between sets. Contractions were 
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evoked using 100 Hz electrical stimulation at the highest stimulation amplitude each 
participant could tolerate. Following the 4 sets, MVC was re-tested. If a ~40% decrease 
in MVC was not observed, additional sets of 10 contractions were performed, after 
which MVC was again assessed. Eccentric exercise proceeded in this manner until 
MVC declined ~30%. 
 
Analysis 
 
All tests were perfomend using SPSS version 19. Paired t-tests were conducted 
to identify differences between pre-EIMD and post-EIMD CF, IAT and NIRS. A one-
way ANOVA was run on the VAS scale for pre, post, and 48-hours post eccentric 
exercise. A 2x10 repeated measures ANOVA was run on EMG RMS and median 
frequency. Α level was set a priori at p<0.05.  
Critical Torque Calculation The average torque was obtained from the plateau of each 
3-second contraction. The data for the final 6 contractions was then averaged and taken 
as critical torque. 
Impulse Above End Test Torque IAT was calculated as the area under the torque curve 
but above the level of critical torque using the trapezoid method. 
NIRS Calculation NIRS data was converted into a text view. From each 10-second 
occlusion following isometric exercise, an 8 seconds of data was plotted as [HB] vs 
time to find the slope. All the slopes were then plotted against time to allow an 
exponential decay fit from which a time constant was calculated. 
EMG The root mean square was averaged from the plateau of each 3-second 
contraction. Median frequency was calculated from the raw EMG signal during the 
plateau. Data was averaged over 6 consecutive contractions at a time. 
25 
CHAPTER IV 
RESULTS 
 
 
 A total of 8 participants were included in the analysis for this study (females n = 
2 males n = 6). One participant out of the 8 was excluded from the analysis of 
mitochondrial function due to their data being deemed an outlier (>2.5 SD’s above the 
mean response). Participants in the study were 22.6 ± 4.2 yrs old with a height of 178.5 
± 6.7cm and weight of 79.3 ± 19.9kg 
 
Assessments of EIMD 
 MVC was decreased -22% (p=0.006; Cohen’s d = -0.84 SD; Figure 1A) 48-
hours post the eccentric exercise protocol. Rating of muscle soreness increased from 
pre-eccentric exercise to immediately following the eccentric exercise protocol (p = 
0.002; Figure 1B). Rating performed 48-hours following the eccentric exercise protocol 
were increased compared to rating performed directly post damage (p = 0.004) and 
compared to rating performed pre-damage to 48-hours post damage (p = 0.002).  
Figure 1 
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Critical Torque and Impulse Above Critical Torque 
 A plot of the mean critical torque values over each of the 60 contractions 
performed in the control and EIMD condition can be seen in Figure 2.  
Figure 2 
 
 
Critical torque was reduced -9.5% in the EIMD condition compared to control condition 
(p = 0.04; d = -0.42 SD; Figure 3). IAT was also reduced (p = 0.008; Figure 4) in the 
EIMD condition compared to the control condition, but this reduction was larger in 
magnitude (-36% with an effect size of d = -0.84 SD) than the reduction in CT.   
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Figure 3 
 
 
Figure 4 
 
Muscle Activation 
 Average RMS values over each 30 second period (covering 6 consecutive 
contractions) during the CT test can be seen in Figure 5.  There was not a significant 
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condition x time interaction (p = 0.28), nor were there significant main effects for 
condition (p = 0.95) or time (p = 0.31). 
 
Figure 5 
 
Data for median frequency was also averaged over each 30 second period (covering 5 
contractions) during the CT test and can be seen in Figure 6. There was not a significant 
condition x time interaction (p = 0.15). There was also not a significant main effect for 
condition (p = 0.57). There was a significant main effect for time (p = 0.001). A 
Bonforroni post-hoc analysis was run, and all time points were significantly reduced 
compared to the value from the initial 30-sec period of the test (p ≤ 0.05).  
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Figure 6 
 
 
Mitochondrial Function  
Mean time constants from the mitochondrial function test are shown in Figure 7. EIMD 
had no effect on the recovery time constants when compared to the control condition (p 
= 0.69). 
Figure 7 
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CHAPTER V 
DISCUSSION 
 
 
 There is a growing body of evidence that critical power is one of the strongest 
physiological predictors of endurance exercise performance/tolerance [56-58]. It is also 
well established that eccentric exercise induced damage to skeletal muscle alters 
disrupts sarcomere integrity [16] and leads to a sequelae of secondary issues such as 
loss of force production [15, 18, 19, 54], decreases in range-of-motion [54], and 
delayed-onset muscle soreness [18, 19, 54]—all of which may work in concert to 
decrease physical function. EIMD has been shown to compromise in movement 
economy [17], decrease peak VO2 [18, 19], increase inflammatory cytokines in brain 
areas related to volitional fatigue [59], and decreased power outputs [18, 60]. Whether 
or not EIMD directly impairs oxidative metabolic function is still unclear with some 
studies showing no impairments during exercise [22] and others finding subtle, but 
measurable changes in the Pi  to PCr ratio [20, 21]. With critical power likely being 
dependent on aerobic metabolic function, a compromise in mitochondrial function and 
VO2 peak as a result of EIMD could result in a lowering of critical power and explain 
some of the reduced exercise tolerance observed in previous studies. Therefore this 
study had two primary aims: 1) to determine whether EIMD in the knee extensors 
altered the work-time relationship as assessed by critical torque and 2) to determine 
whether EIMD altered mitochondrial function of the quadriceps muscles as assessed by 
NIRS. The primary novel findings of this study were that EIMD reduced critical torque 
9.5% and impulse above end test torque (i.e W’) was decreased by 36%. Interestingly, 
an accompanying reduction in mitochondrial function was not observed.  
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Confirmation of EIMD 
 To determine whether participants were successfully damaged following the 
eccentric exercise protocol, MVC was measured immediately following eccentric 
exercise and 48-hours later—prior to the final critical torque test. Ratings of perceived 
muscle soreness were provided using a VAS scale prior to and immediately following 
eccentric exercise as well as 48-hour post damage. A significant decline in MVC was 
been shown to be the most valid “indirect” marker of significant EIMD and myofibullar 
disruption [61]. All participants included in the analysis displayed a significant decrease 
(-22%) in MVC. The 4 excluded participants showed either a very small (>5%) 
reduction, no reduction, or an increase in MVC 48-hours following eccentric exercise. 
We were therefore confident that we had successfully induced muscle damage in the 
participants included in the analysis. 
 
EIMD and Critical Torque 
 To our knowledge this is the first study to examine the effects of EIMD on the 
work-time relationship. Our findings of a significant reduction in critical torque 
following EIMD are consistent with previous studies demonstrating impairments in 
physical function and exercise tolerance following EIMD [17-19, 45, 60]. It has been 
shown that critical torque can be manipulated without changes in training status. 
Moritani et al. [9] found that critical power was decreased when tests were performed in 
hypoxic conditions and a recent study by Broxterman et al. [24] found that critical 
power decreased during blood flow occlusion to the exercising muscles. Additionally, 
critical power has been shown to increase under hyperoxic conditions [5]. Collectively 
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these findings strongly suggest a relationship between CP and aerobic metabolic 
function. The extent to which EIMD alters aerobic function is a matter of some debate. 
Mitochondrial function was shown to be impaired following EIMD in a recent study by 
Foure et al. [62], but this finding is in contrast to several previous investigations who 
found EIMD altered resting mitochondrial metabolism, but not metabolism during 
exercise [20, 22].  In the present study we did not observe significant changes in NIRS 
assessed mitochondrial function. The equivocal findings among studies may be related 
to the different measures used to assess mitochondrial function (P-31 MRS vs. NIRS) 
and to the different magnitudes of EIMD induced in each study as it is plausible that 
greater damage might be required to elicit measurable decrements in mitochondrial 
function.  
 While the effects of EIMD on cellular aerobic metabolism remain somewhat 
unresolved, consist with our findings of reduced CT, EIMD has been shown to decrease 
peak VO2 [18, 19], reduce ventilatory and lactate threshold [18, 19], and to reduce an 
integrative assessment of exercise performance in the form of a cycling time-trial (TT) 
[45]. Interestingly, the magnitude of reduction in CT (-9.5%) observed in the present 
study is quite similar to the magnitude of reduction in VO2 (~10%) [18, 19] and TT 
performance (~6%). Eccentric exercise has been shown to selectively damage type 2 
muscle fibers (Liber & Friden, 1988) which would place a greater metabolic stress upon 
the undamaged type I fibers—even if their oxidative capacity remains uncompromised. 
Attainment of CT is related to the depletion of intramuscular creatine phosphate stores, 
a drop in intramuscular pH from hydrogen ion accumulation, and the accumulation of 
other metabolic by-products. It is therefore plausible that following EIMD greater 
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metabolic stress is placed upon the undamaged muscle fibers leading to an earlier onset 
of lactate accumulation, as observed previously [18, 19], and an earlier onset of 
metabolic acidosis. All of which would lead to a lower of CT.  
 
EIMD and Impulse Above End Test Torque 
 Perhaps the most interesting, and unexpected finding of our experiment was the 
36% reduction in IAT, an isometric analog to W’, following EIMD. EIMD appears to 
disproportionately affect IAT compared to CT (36% reduction vs. a 9.5% reduction). 
The physiological determinants of IAT remain unresolved, but it is thought to be related 
to stored anaerobic energy in the muscle (e.g. creatine phosphate and oxygen), glycogen 
stores, and the accumulation of fatigue inducting metabolites (e.g. inorganic phosphate 
and hydrogen ions) [63]. EIMD has been shown to increase the ratio of Pi to PCr in 
resting skeletal muscle [20, 62] due to an increase in resting Pi and to impair glycogen 
re-synthesis [64, 65] in the days following eccentric exercise. Additionally, EIMD leads 
to the death of a population of muscle fibers and to sub-lethal membrane disruption in 
another population of fibers. As a consequence, the total available store of PCr within a 
muscle has likely decreased. Having less PCr available may play a role in the reduced 
IAT observed in the present study as could an increase in Pi. Previous studies [5, 57] 
have demonstrated exhaustion occurs when certain level of intramuscular Pi are 
achieved. If these levels are higher at rest, it would take less of an increase to reach the 
level required to evoke exhaustion. The most likely explanation is that EIMD alters 
multiple aspects of the intracellular environment leading to earlier depletion of 
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anaerobic stores and attain of critical pH, Pi, and PCr levels thus resulting in a reduced 
IAT.     
 
EMG  
 No differences were observed between the control and EIMD damage in regards 
to EMG RMS and median frequency. RMS provides a rough indicator of skeletal 
muscle activation [38] (i.e. the magnitude of the signal from the central nervous system 
that reaches the muscle and signals for it to generate force). The finding that RMS did 
not differ over time during the CT test nor between conditions provides evidence that 
central motor drive was consistent throughout each CT test. One possible explanation 
for the decline in MVC and potentially CT in this study was that participants did not 
provide a “maximal” effort following EIMD due to DOMS. The RMS findings provide 
evidence this was not the case and that a similar, near maximal effort was provided in 
both conditions. EMG median frequency decreased over time during the CT test in both 
conditions. This finding is consistent with many previous studies (see [66, 67] for 
review). The decrease in median frequency is generally thought to be a consequence of 
slowed action potential propagation [66, 67] along the motor axons and the sarcolemma. 
As such it is a consequence of the development of peripheral fatigue rather than a cause, 
per se, of the fatigue. The similar decline in median frequency between the two 
experimental conditions further confirms a similar motor drive to the muscles and the 
development of a similar level of fatigue over the course of the 60 contractions 
performed in the test.    
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Conclusion 
 The primary aim of this study was to determine the effect or exercise induced 
muscle damage on critical torque and mitochondrial function. We found a 9.5% 
decrease in critical torque and a 36% decrease in impulse above end test torque. These 
decreases were not accompanied by any significant changes in mitochondrial function 
as determined by NIRS. This leads to the thought that critical torque is reliant on more 
than just aerobic capacity. These findings may have large implications on a variety of 
athletes. The drop in critical torque may be important to distance athletes who perform 
at levels near critical torque for extended periods of time. The large drop in impulse 
above end test torque could have severe implications on intermittent sports such as 
rugby and soccer, where athletes cross back and forth between the heavy and severe 
exercise domains  
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APPENDIX A: INFORMED CONSENT 
 
Consent Form 
University of Oklahoma, Norman Campus (OU) 
University of Oklahoma Health Sciences Center (OUHSC) 
 
EFFECTS OF EXERCISE INDUCED MUSCLE DAMAGE ON CRITICAL 
TORQUE AND MITOCHONDRIAL FUNCTION 
 
Principle Investigator: Christopher D. Black, Ph.D. 
Sponsor: Department of Health and Exercise Science 
 
 
 
This is a research study. Research studies involve only individuals who choose to 
participate. Please take your time to make your decision. Discuss this with your family and 
friends. 
 
Why Have I Been Asked To Participate In This Study?  
You are being asked to take part in this study because you are recreationally active (e.g., 
you participate in physical activity less than 5 hours per week) and have participated in 
little or no lower body resistance training in the past 6 months. 
 
Why Is This Study Being Done?  
The purpose of this study is to determine the effects of muscle damaging exercise on 
critical strength and mitochondrial (cell energy) function in the knee extensor muscles. 
 
How Many People Will Take Part In The Study? 
About twenty people (men or women) between the ages of 18-40 will take part in this 
study. 
 
What Is Involved In The Study?  
You will be asked to complete various health history and screening questionnaires 
prior to beginning the study. You will be asked to complete two days of 
familiarization, and three days of experimental testing. Familiarization days will take 
roughly 45-60 minutes. Testing days will take roughly 60- 75 minutes. 
 
How Long Will I Be In The Study?  
You will be visiting the laboratory five times. A minimum of 48 hours will separate 
the familiarization trials from the testing trials (visit 2 from visit 3). 48 hours will 
separate the muscle damage day from the final visit (visit 4 from visit 5). The total 
time commitment is ~5-6 hours over 6-7 days 
 
The following list is provided to detail your involvement in the study. 
Visit 1:  
• Forms and Questionnaires: Written and verbal descriptions of the experiment 
will be provided, and any questions will be answered. You will be asked to fill 
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out a physical activity readiness questionnaire (PAR-Q), medical history 
questionnaire, and a rhabdomyolysis risk assessment questionnaire.  
• Resting blood pressure: A measurement of your resting blood pressure will be 
taken after a few minutes of resting in a seated position. The blood pressure cuff 
will be placed around your upper arm and will inflate and then deflate to 
determine your blood pressure.   
• Equipment Familiarization- KinCom, Maximal Strength, Critical Strength 
Test:   
You will be seated in a KinCom isokinetic dynamometer machine. Your hip and 
knee angles will be adjusted to specific positions, and your body will be secured 
to the seat and attachments with straps. You will then be asked to perform three 
3-second maximal voluntary contractions (MVCs) separated by 3 minutes rest 
each. An MVC is an assessment of the maximal strength of your thigh muscles 
and it will be determined by asking you to extend your leg as forcefully as 
possible. Following the final MVC, a 2-minute break will be provided followed 
by a 2-minute exercise protocol involving rhythmical MVCs at a cadence of a 3-
second contraction followed by 2 seconds rest.   
• Equipment Familiarization- Near-infrared Spectroscopy: You will be asked 
to lie on your back on a table. Your ankle will be put in a raised position, and a 
blood pressure cuff will be fastened around your upper thigh. This cuff will 
undergo a series of inflations (to approximately 250-280 mmHg) of different 
durations to allow for familiarization to the cuff location and sensations of 
inflation/deflation. During this period of time a near-infrared spectrometer will 
be placed on your thigh. This device sends light signals into blood, muscle and 
fat tissue. Some light that is sent comes back to the sensor from the muscle, fat, 
and blood, while some light is lost due to deflection  
 
Visit 2: 24-72 hours after Visit 1 
• You will repeat familiarization protocols in the same manner as Visit 1.  
 
Visit 3: 24-72 hours after Visit 2  
• Recall Questionnaire: You will be asked to fill out a recall 
questionnaire regarding your diet and exercise over the last 24 hours   
• Near-infrared Spectroscopy: You will assume the same supine position as 
during familiarization. The pressure cuff will be secured around the upper 
thigh, and the near-infrared probe will be secured to your thigh. The cuff 
will then be inflated for 60 seconds, followed by 3-5 minutes of rest and 
then the cuff will be inflated again for 60 seconds followed by 3-5 minutes 
of rest. You will then be asked to perform a brief series of knee extensions 
using a light weight attached to your ankle. This will be followed by 5-6 
minutes of rhythmical cuff inflation at a cadence of 10 seconds of inflation 
followed by 10 seconds deflation. The near-infrared spectroscopy protocol 
will take place two times.   
KinCom Maximal Strength and Critical Strength: You will be seated in 
the KinCom machine in the same manner as during familiarization trials. A 
set of electrodes will be placed on your thigh (to measure the electrical 
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activity of the muscle during exercise) and the near-infrared spectroscopy 
probe will be placed on your thigh as well (shaving of body hair may be 
necessary). You will then be asked to perform three 3-second maximal 
voluntary contractions (MVCs) separated by 3 minutes rest each. An MVC 
is an assessment of the maximal strength of your thigh muscles and it will 
be determined by asking you to extend your leg as forcefully as possible. 
You will be then asked to perform rhythmical MVCs following a cadence 
of 3-seconds of contraction to 2-seconds of rest for 5 minutes. 
 
Visit 4: 24-72 hours after Visit 3  
• Rating of perceived muscle soreness: You will be asked to perform a single 
leg squat with your dominant leg, and indicate on a scale your current soreness 
level of the quadriceps. This will occur three times in a row.   
• KinCom Eccentric Exercise: You will be seated in the KinCom in a similar 
matter as in the previous visit. Two electrical stimulation pads will be placed on 
your thigh muscles. Electrical current will then be applied to the pads in order to 
make your thigh muscles contract. The current will be increased until you 
decide it has become uncomfortable. It will then be reduced to the highest level 
you find comfortable. Three, 3-second MVCs will then be taken. You will be 
then perform 4 sets of 10 of isokinetic eccentric knee flexions where electrical 
stimulation will be applied to your thigh muscles so they contract against the 
KinCom machine as it pushes your leg downward. MVC will be assessed after 
the 4 sets. If your MVC has not declined by ~30% then you will perform 
additional sets of 10 eccentric knee flexions until your MVC declines by ~30%.   
• Rating of perceived muscle soreness: You will once again be asked to 
perform 3 single leg squats and indicate current soreness level.  
 
Visit 5: 48 hours after Visit 4  
• You will be asked to rate your feelings of muscle soreness as described 
previously, and then visit 5 will proceed in an identical manner to visit 3.  
 
There may be certain circumstances in which your participation may be terminated 
by the investigator without regard to your consent.  
For example:  
• If you have taken any vitamins, consumed alcohol, or taken any drugs prior to 
testing   
• If it is in your best medical interest  
• You fail to follow study requirements  
• The study is stopped by the sponsor  
 
What Are The Risks of The Study?  
• You may experience heavier than normal breathing from the exercise protocols 
used in this study.   
• You may find the KinCom seat or attachments uncomfortable.   
• You may experience muscle soreness for several days after the eccentric 
exercise protocol.   
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• You may experience rhabdomyolysis from the eccentric exercise protocol. 
Rhabdomyolysis is a potentially serious condition, although uncommon in 
recreationally active individuals, caused by a breakdown of muscle tissue 
that releases a damaging protein into the blood. This is extremely unlikely, 
<1%.  
• Inflation of the blood pressure cuff may cause temporary discomfort and 
will stop when pressure in the cuff is decreased.  
 
There are no other known risks associated with the protocols outlined in the 
proposal. Exercise testing of apparently healthy subjects under laboratory 
supervision is safe.  
According to recent American College of Sports Medicine’s Guidelines for Exercise 
Testing, the exercise tests described above can be safely performed in individuals who 
meet this studies inclusion criterion. 
 
For more information about risks and side effects, ask the researcher if you have 
questions at any time. 
 
Are There Benefits to Taking Part in The Study?  
If you agree to take part in this study, there is no medical benefit to you. We hope the 
information learned from this study will benefit clinical and athletic populations with 
possible interventions and guidelines for anyone that may experience muscle soreness 
from unaccustomed physical activity. 
 
What Other Options Are There? 
You may choose not to participate. 
 
What About Confidentiality?  
Efforts will be made to keep your personal information confidential. You will not be 
identifiable by name or description in any reports or publications about this study. We 
cannot guarantee absolute confidentiality. Your personal information may be disclosed 
if required by law. You will be asked to sign a separate authorization form for use or 
sharing of your protected health information. 
 
There are organizations that may inspect and/or copy your research records for 
quality assurance and data analysis. These organizations include the Department 
of Health and Exercise Science and the OUHSC Institutional Review Board. 
 
What Are the Costs? 
As a participant, you will not incur any additional costs. 
 
Will I Be Paid For Participating in This Study? 
Yes, you will receive a $20 gift card for your participation. 
 
What if I am Injured or Become Ill While Participating in this Study?  
In the case of injury or illness resulting from this study, emergency medical 
treatment is available. No funds have been set aside by The University of Oklahoma 
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Health Sciences Center, The University of Oklahoma-Norman, or the principle 
investigator to compensate you in the event of injury. 
 
The current study involves low risk; however, there is always the possibility 
of a problem during exercise. Therefore, in case of a medical emergency the 
phone numbers for campus police (405-325-2864), Goddard Health Center 
(405-325-4611), Norman police (911), ambulance (911), and fire 
department (911) are posted in the testing room and research laboratory 
suite. Medical professionals are within minutes of the testing labs. All 
investigators are CPR, and Automated External Defibrillator certified. The 
P.I. will be present at each experimental visit or immediately available if 
needed. 
 
What Are My Rights As a Participant?  
Taking part in this study is voluntary. You may choose not to participate. 
Refusal to participate will involve no penalty or loss of benefits to which you 
are otherwise entitled. If you agree to participate and then decide against it, you 
can withdraw for any reason and leave the study at any time. Please discuss 
leaving the study with the principal investigator. You may discontinue your 
participation at any time without penalty or loss of benefits, to which you are 
otherwise entitled. 
 
We will provide you with any significant new findings developed during the 
course of the research that may affect your health, welfare or willingness to 
continue your participation in this study. 
 
You have the right to access the medical information that has been collected 
about you as a part of this research study. However, you may not have access to 
this medical information until the entire research study has completely finished 
and you consent to this temporary restriction.  
Whom Do I Call If I have Questions or Problems?  
If you have questions, concerns, or complaints about the study or have a 
research-related injury, contact Dr. Christopher Black at 706-255-3750 (cell) or 
405-325-7668 (office).  
If you cannot reach the Investigator or wish to speak to someone other than the 
investigator, contact the OUHSC Director, Office of Human Research Participant 
Protection at 405-271-2045. 
 
For questions about your rights as a research participant, contact the 
OUHSC Director, Office of Human Research Participant Protection at 405-
271-2045. 
 
Signature:  
By signing this form, you are agreeing to participate in this research study under 
the conditions described. You have not given up any of your legal rights or 
released any individual or entity from liability for negligence. You have been 
given an opportunity to ask questions. You will be given a copy of this consent 
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document. 
 
 
I agree to participate in this study:   
_________________________________ _______________________ _________ 
PARTICIPANT SIGNATURE (age >18) Printed Name Date 
(Or Legally Authorized Representative)   
_________________________________ _______________________ _________ 
SIGNATURE OF PERSON Printed Name Date 
OBTAINING CONSENT 
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APPENDIX B: HIPPA FORM 
 
AUTHORIZATION TO USE or 
DISCLOSE PROTECTED HEALTH 
INFORMATION FOR RESEARCH  
An Informed Consent Document for Research Participation may also 
be required. Form 2 must be used for research involving 
psychotherapy notes. 
 
Title of Research Project: Effect of Exercise Induced Muscle Damage on Critical 
Torque and 
 
Mitochondrial Function 
 
Leader of Research Team: Christopher D. Black., Ph.D. 
 
Address: 1401 Asp Ave., #110 HHC, Norman, OK 73019 
 
Phone Number: 405-325-7668 (office); 706-255-3750 (cell) 
 
If you decide to join this research project, University of Oklahoma Health Sciences 
Center (OUHSC) researchers may use or share (disclose) information about you that is 
considered to be protected health information for their research. Protected health 
information is information about past, present, and future medical treatment or 
condition that is identifiable to you. It will be called PHI in this Authorization. 
 
PHI To Be Used or Shared. Federal law requires that researchers get your permission 
(authorization) to use or share your PHI. If you give permission, the researchers may 
use or share with the people identified in this Authorization any PHI related to this 
research from your medical records and from any test results. Information used or 
shared may include all information relating to any tests, procedures, surveys, or 
interviews as outlined in the consent form; medical records and charts; name, address, 
telephone number, date of birth, race, and government-issued identification numbers. 
 
Purposes for Using or Sharing PHI. If you give permission, the researchers may 
use your PHI to determine if it is safe for you to participant in the exercise used in 
this study. 
 
Other Use and Sharing of PHI. If you give permission, the researchers may also use 
your PHI to develop new procedures or commercial products. They may share your 
PHI with other researchers, the research sponsor, and its agents, the OUHSC 
Institutional Review Board, auditors and inspectors who check the research, and 
government agencies such as the Food and Drug Administration (FDA) and the 
Department of Health and Human Services (HHS). The researchers may also share 
your PHI with your physician and/or a Univeristy of Oklahoma physician in the event 
of a serious health risk or adverse event that occurs during the study. 
 
Confidentiality. Although the researchers may report their findings in scientific 
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journals or meetings, they will not identify you in their reports. The researchers will 
try to keep your information confidential, but confidentiality is not guaranteed. The 
law does not require everyone receiving the information based on this authorization 
to keep it confidential, so they could release it to others, and federal law may no 
longer protect it. 
 
YOU UNDERSTAND THAT YOUR PROTECTED HEALTH INFORMATION 
MAY INCLUDE INFORMATION REGARDING A COMMUNICABLE OR 
NONCOMMUNICABLE DISEASE. 
 
Voluntary Choice. The choice to give OUHSC researchers permission to use or 
share your PHI for their research is voluntary. It is completely up to you. No one can 
force you to give permission. However, you must give permission for OUHSC 
researchers to use or share your PHI if you want to participate in the research and, if 
you cancel your authorization, you can no longer participate in this study. 
 
Refusing to give permission will not affect your ability to get routine treatment or 
health care from OUHSC. 
 
Cancelling Permission. If you give the OUHSC researchers permission to use or share 
your PHI, you have a right to cancel your permission whenever you want. However, 
cancelling your permission will not apply to information that the researchers have 
already used, relied on, or shared. 
 
End of Permission. Unless you cancel it, permission for OUHSC researchers to 
use or share your PHI for their research will never end. You may cancel your 
permission at any time by writing to: 
 
Privacy Official or Privacy Board 
University of Oklahoma Health Sciences Center  
University of Oklahoma Health  
Sciences Center 
PO Box 26901  PO Box 26901 
Oklahoma City, OK 73190  Oklahoma City, OK 73190 
If you have questions, call: (405) 271-2511 or (405) 271-2045. 
 
Access to Information. You have the right to access the medical information that 
has been collected about you as a part of this research study. However, you may not 
have access to this medical information until the entire research study is completely 
finished. You consent to this temporary restriction. 
 
Giving Permission. By signing this form, you give OUHSC and OUHSC’s researchers 
led by  
Christopher D. Black, permission to share your PHI for the research project called 
Effect of Exercise Induced Muscle Damage on Critical Torque and Mitochondrial 
Function 
 
Patient/Participant Name: _________________________  
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__________________________________________ _______________ 
Signature of Patient-Participant Date 
  or Parent if Participant is a minor 
Or 
 
__________________________________________ _______________ 
Signature of Legal Representative** Date 
 
**If signed by a Legal Representative of the Patient-Participant, provide a 
description of the relationship to the Patient-Participant and the Authority to 
Act as Legal Representative: 
 
______________________________________________________________________
_ 
OUHSC may ask you to produce evidence of your relationship. 
 
A signed copy of this form must be given to the Patient-Participant or the Legal 
Representative at the time this signed form is provided to the researcher or his 
representative.       IRB No.: 5887 
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APPENDIX C: HEALTH STATUS QUESTIONNAIRE 
 
Health Status Questionnaire 
 
 
 
Part 1.  Information about the individual 
 
1.  ____________________________________  
     Date 
 
2.  _________________________________________ ____________________ 
     Legal Name      Nickname 
 
3.  _________________________________________ ____________________ 
      Mailing Address     Home Phone 
     _________________________________________ ____________________ 
       Cell or Business Phone 
 
4.  _______________________________________ ______________________ 
       Personal Physician    Phone 
     _______________________________________ 
       Address 
 
5.  _______________________________________ ______________________ 
     Person to contact in emergency   Phone 
 
6.  Gender (circle one)  Female  Male 
 
7. Age ________ 
 
8. Height ____________    Weight___________      
 
9.  Do you smoke?     Yes          No 
 
10.  If you are a smoker, indicate number smoked per day: 
 Cigarettes: 40 or more          20-39          10-19          1-9 
 Cigars or pipes only: 5 or more or any inhaled  Less than 5, none inhaled 
 
11. Are you currently taking prescription or over-the-counter medication(s)? If so, please list the 
medication, daily dose, and why you are taking it. 
 
 
 
 
 
12. Are you currently taking any vitamins or nutritional supplements? If so, please list the 
vitamin/supplement, the daily dose, and why you are taking it. 
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Part 2.  Medical History 
 
Assess your health needs by marking all true statements 
 
History  
You have had:  
___ A heart attack  
___ Heart surgery  
___ Cardiac catheterization  
___ Coronary angioplasty (PTCA)  
___ Pacemaker-implantable cardiac defibrillatory/ rhythm disturbance  
___ Heart valve disease  
___ Heart failure  
___ Heart transplantation  
___ Congenital heart disease 
___ Peripheral arterial disease 
___ Stoke   
 
Signs/Symptoms  
___ You experience discomfort and/or pain with exertion in the chest, neck, jaw, arms   
___ You experience unreasonable breathlessness at rest or with mild exertion 
___ You experience dizziness, fainting, or blackouts 
___ You experience ankle edema 
___ You experience heart palpitations or tachycardia (unpleasant awareness of force or rapid 
heart beats) 
___ You have or experience intermittent claudication (muscle pain due to ischemia) 
___ You have a heart murmur  
___ You take medication(s) for ANY type of heart condition or high blood pressure 
 
Other health issues  
___ You have diabetes 
___ You have a thyroid disorder 
___ You have a renal (kidney) disorder 
___ You have  liver disease (e.g. cirrhosis)  
___ You have COPD, asthma, cystic fibrosis or other lung disease  
___ You have burning or cramping sensation in your lower legs when walking short distances  
___ You have musculoskeletal problems that limit your physical activity (arthritis, etc.)  
___ You are pregnant  
 
 
 
If you answered yes to any of these statements please consult your 
physician or appropriate health care professional before engaging in 
exercise.  
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Part III: Cardiovascular Risk Factors 
 
 Age 
___ You are a man older than 45 years  
___ You are a woman older than 55 years, have had a hysterectomy, or are postmenopausal 
  
Medical/Lifestyle  
___ You smoke, or quit smoking within the previous 6 months 
  
___ Your blood pressure is >140/90 mm Hg and has been confirmed by a doctor on two 
separate occasions      BP ____________ 
   
___ Your blood cholesterol level is >200 mg/dl or LDL cholesterol is >130 mg/dl  
 
___ You have a close blood relative who had a heart attack or heart surgery before age 55 
(father or        brother) or age 65 (mother or sister) 
  
___ You are physically inactive (i.e., you get <30 minutes of physical activity 3 days per week) 
 
___ You have impaired fasting glucose (> 100mg/dl) that has been confirmed by a doctor on 
two separate occasions 
  
___ Your BMI is >30   BMI___________ 
 
 
ACSM Risk Stratification Category 
 
Low Risk Men < 45and women < 55 years of age who did not mark more than 1 
medical/lifestyle factor 
 
Moderate Risk Men ≥ 45 and women ≥ 55 years of age, or those who marked 2 or 
more medical/lifestyle factors  
 
High Risk  Individuals who marked one or more statements under Medical History  
 
 
I understand my signature signifies that I have read and understand all the information on the 
questionnaire, that I have truthfully answered all the questions, and that any questions/concerns 
I may have had have been addressed to my complete satisfaction.  
 
Name (please print) ____________________________________________________________ 
 
Signature _______________________________________________ Date _________________  
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APPENDIX D: PHYSICAL ACTIVITY READINESS 
QUESTIONNAIRE 
 
PAR-Q & YOU 
(A questionnaire for People Aged 15-69) 
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being 
more active is very safe for most people. However, some people should check with your doctor before you start.  
 
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box 
below. If you are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If 
you are over 69 years of age, and you are not used to being very active, check with your doctor. 
 
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one 
honestly: check YES or NO 
 
  
YES      NO  
1. Has your doctor ever said that you have a heart condition and that you should only do physical 
activity recommended by a doctor? 
YES      NO  2. Do you feel pain in your chest when you do physical activity? 
YES      NO  3. In the past month, have you had chest pain when you were not doing physical activity? 
YES      NO  4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
YES      NO  
5. Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse 
by a change in your physical activity? 
YES      NO  
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or 
heart condition? 
YES      NO  7. Do you have a diabetes or thyroid condition? 
YES      NO   8. Do you know of any other reason why you should not do physical activity? 
 
 
If 
 
you 
 
answered 
 
“Yes”: 
YES to one or more questions 
A medical clearance form is required of all participants who answer ‘yes’ to any of the eight PAR-Q questions.   
Note: Personal training staff reserve the right to require medical clearance from any client they feel may be at risk. 
•    
Discuss with your personal doctor any conditions that may affect your exercise program. 
•    
All precautions must be documented on the medical clearance form by your personal doctor. 
 
 
NO to all questions 
If you answered NO honestly to all PAR-Q questions, you 
can be reasonably sure that you can:  
•    start becoming much more physically 
active - begin slowly and build up 
gradually. This is the safest and easiest 
way to go. 
•    take part in a fitness appraisal - this is an 
excellent way to determine your basic 
fitness so that you can plan the best way 
for you to live actively. It is also highly 
recommended that you have your blood 
pressure evaluated. If your reading is over 
144/94, talk with your doctor before you 
start becoming much more physically 
 
DELAY BECOMING MUCH MORE 
ACTIVE:  
•    If you are not feeling well because of 
a temporary illness such a cold or a 
fever - wait until you feel better; or 
•    If you are or may be pregnant - talk 
to your doctor before you start 
becoming more active. 
 
 
PLEASE NOTE:  If your health changes so that you 
then answer YES to any of the above questions, tell 
your fitness or health professionals. 
Ask whether you should change your physical activity 
plan. 
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active. 
 
 
 
Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability to persons who undertake physical 
activity, and if in doubt after completing this questionnaire, consult your doctor prior to physical activity. 
  
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or 
administrative purposes. 
 
“I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction.” 
 
NAME_____________________________________________________________________ 
 
SIGNATURE________________________________________________________________
 DATE____________________________________________________________ 
 
SIGNATURE OF PARENT_____________________________________________________
 WITNESS_________________________________________________________ 
or GUARDIAN (for participants under the age of majority) 
 
Note: This physical activity clearance is valid for a maximum of 12 months from the date it is 
completed and becomes invalid if your condition changes so that you would answer YES to any 
of the seven questions. 
 
 Supported by:     Physical 
Activity Readiness Questionnaire – PAR-Q            
(revised 
2006 by CW) 
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APPENDIX E: RHABDOMYOLYSIS SCREENING 
QUESTIONNAIRE 
 
Screening questionnaire 
Participant ID:__________ 
Date: __________    
 
1. Do you participate in some form of physical activity at least 3 days per week?     
  Yes   or    No 
 
2. If you answered “Yes” to #1, please list and describe the type  and frequency of activity in 
which you typically engage 
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
________________________________________________ 
 
3. Have you had any shoulder, elbow, and/or wrist injuries in the previous 6 months?    
  Yes   or   No  
  
4. Have you taken any type of pain relievers within the previous 7 days?      
  Yes   or    No 
 
5. Are you taking any medications, prescription or over-the-counter including birth control? 
  Yes   or    No 
 
6. If you answered “Yes” to #4 or 5, please list the medications, the reasons for taking them, 
the prescribed dosage, and how long you have been taking them on a consistent basis.  
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
________________________________________________ 
 
7. Have you consumed any alcohol, tranquilizers, sleeping pills, antidepressants, opiates, 
cocaine, amphetamines, PCP, or barbiturates within the previous 7 days days?     
     Yes   or    No 
 
8. Have you consumed any antibiotics, laxatives, diuretics, neuroleptics,  
or theophyline within the previous 7  days?        
  Yes   or    No   
 
9. Are you consuming any performance enhancing drugs?      
  Yes   or    No   
 
10. Are you consuming any vitamins or dietary supplements?    
  Yes   or    No   
 
11. If you answered “Yes” to #7 to 10, please list what you have been taking? 
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_____________________________________________ 
 
12. Have you been ill within the previous week or are you currently ill (cold, flu, etc.)?      
  Yes   or    No 
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13. Have you made in changes in your diet in the last month?    
  Yes   or    No 
 
14. Do you have to maintain a specific type of diet for any reason?   
  Yes   or    No 
 
15. If so, why are you having to maintain the diet? 
_______________________________________________________________________
_______________________________________________________________________
________________________________ 
 
16. Have you been diagnosed with diabetes or high blood pressure?      
  Yes   or    No 
 
17. Do you have any history of kidney or liver dysfunction?       
  Yes   or    No 
 
18. Do you have any history of heat illness?          
  Yes   or    No 
 
19. Do you have any history of swelling after exercise?        
  Yes   or    No 
 
20. Do you have any history of bruising easily?         
  Yes   or    No 
 
21. Do you have a family history of muscle disease?         
  Yes   or    No 
 
22. Are you currently undergoing statin or thyroid replacement therapy?     
  Yes   or    No 
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APPENDIX F: VISUAL ANALOG SCALE 
 
Visual analog pain intensity scale 
 
 
 
 
 
No pain at all 
 _______________________________________________   
 
Most intense pain imaginable 
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APPENDIX G: IRB APPROVAL LETTER 
 
 
Institutional Review Board for the Protection of Human 
Subjects Initial Submission – Board 
Approval 
 
 
Date: October 23, 2015 IRB#: 5887  
Meeting Date: 10/19/2015  
To:  Christopher D Black, PhD Approval Date: 10/23/2015  
Expiration Date: 09/30/2016  
Study Title: Effect of Exercise Induced Muscle Damage on Critical Torque and Mitochondrial 
Function 
 
Reference Number: 643253  
Study Status: Active - Open  
Collection/Use of PHI: Yes 
 
At its regularly scheduled meeting the IRB reviewed the above-referenced research study. 
Study documents (e.g. protocol, consent, survey, etc.) associated with this submission are 
listed on page 2 of this letter. To review and/or access the submission forms (e.g. application) 
as well as the study documents approved for this submission, open this study from the My 
Studies option, click to open this study, look under Protocol Items to click on the current 
Application, Informed Consent and Other Study Documents. 
 
If this study required routing through the Office of Research Administration (ORA), you 
may not begin your study yet, as per OUHSC Institutional policy, until the contract 
through ORA is finalized and signed. 
 
As principal investigator of this research study, it is your responsibility to:  
• Conduct the research study in a manner consistent with the requirements of the IRB 
and federal regulations at 45 CFR 46 and/or 21 CFR 50 and 56.  
• Request approval from the IRB prior to implementing any/all modifications.   
• Promptly report to the IRB any harm experienced by a participant that is both 
unanticipated and related per IRB Policy.   
• Maintain accurate and complete study records for evaluation by the HRPP quality 
improvement program and if applicable, inspection by regulatory agencies and/or the 
study sponsor.   
• Promptly submit continuing review documents to the IRB upon notification 
approximately 60 days prior to the expiration date indicated above.  
 
In addition, it is your responsibility to obtain informed consent and research privacy 
authorization using the currently approved, stamped forms and retain all original, signed 
forms, if applicable. 
 
If you have questions about this notification or using iRIS, contact the IRB @ 405-
271-2045 or irb@ouhsc.edu. 
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Sincerely, 
 
 
 
 
 
 
 
 
 
Study documents associated with this submission: 
 
Study Document  
Title 
Version 
Number Version Date Outcome 
VAS Scale Version 1.0 09/01/2015 Approved 
Rhabo Risk Assessment Version 1.0 09/01/2015 Approved 
Par-Q Version 1.0 09/01/2015 Approved 
HIPAA Form Version 1.1 09/01/2015 Approved 
Email Recruitment Script Version 1.1 09/01/2015 Approved 
Recruitment Flyer Version 1.1 09/01/2015 Approved 
Protocol Version 1.2 09/01/2015 Approved 
Medical History Version 1.1 09/01/2015 Approved 
    
Study Consent Form    
Title 
Version 
Number Version Date Outcome 
EIMD and Critical Torque Consent Version 1.7 10/21/2015 Approved 
 
 
**Information for Industry Sponsors: the columns titled Version Number and 
Version Date are specific to the electronic submission system (iRIS) and 
should not to be confused with information included in the Document and/or 
Consent title(s).** 
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APPENDIX H: IRB REVISION 
 
Institutional Review Board for the Protection of Human Subjects  
Modification/Notification – Expedited Approval 
 
 
Date: February 11, 2016 IRB#: 5887 
Approval Date: 02/11/2016  
To: Christopher D Black, PhD 
 
Study Title: Effect of Exercise Induced Muscle Damage on Critical Torque and Mitochondrial 
Function 
 
Reference Number: 648336  
Modification/Notification Summary: Changing the eccentric exercise protocol from maximal 
voluntary contractions to electrically stimulated contractions in order to normalize the location 
of the muscle damage among participants and to the location where the EMG and NIRS 
measures will be made. Additionally, participant compensation has been added in the form of 
a $20 gift card. 
 
On behalf of the Institutional Review Board (IRB), I have reviewed and granted expedited 
approval of the above-referenced modification/notification. To review and/or access the 
submission form (e.g. modification form) as well as the study documents approved for this 
submission, open this study from the My Studies option, look under Protocol Items, click to 
open/view the current approved Application,  
Informed Consent, or Other Study Documents. 
 
If this modification includes revisions to the consent or privacy authorization forms, you are 
reminded to obtain informed consent and research privacy authorization using the currently 
approved, stamped forms and retain all original, signed forms, if applicable. 
 
If you have questions about this notification or using iRIS, contact the HRPP office at (405) 
271-2045 or irb@ouhsc.edu. The HRPP Administrator assigned for this submission: Rebecca 
R Hicks. 
 
Sincerely, 
 
 
 
 
 
 
 
 
Study documents associated with this submission:  
Study Document  
Title 
Version 
Number Version Date Outcome 
Email Recruitment Script Version 1.2 02/02/2016 Approved 
Recruitment Flyer Version 1.2 02/02/2016 Approved 
Protocol Version 1.5 02/02/2016 Approved 
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Study Consent Form    
Title 
Version 
Number Version Date Outcome 
EIMD and Critical Torque Consent Version 1.10 02/02/2016 Approved  
**Information for Industry Sponsors: the columns titled Version Number and Version Date are specific to the electronic submission 
system (iRIS) and should not to be confused with information included in the Document and/or Consent title(s).** 
 
